Reference-Feb-22-O1
[1] Chaudhary, A., Maurya, P., Yadav, B., Singh, S., & Mani, A. (2018). Current Therapeutic Targets for Alzheimer’s Disease. Journal Of Biomedicine, 3, 74-84. doi: 10.7150/jbm.26783
[2] Athar, T., Al Balushi, K., & Khan, S. (2021). Recent advances on drug development and emerging therapeutic agents for Alzheimer’s disease. Molecular Biology Reports. doi: 10.1007/s11033-021-06512-9
[3] Fish, P., Steadman, D., Bayle, E., & Whiting, P. (2019). New approaches for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry Letters, 29(2), 125-133. doi: 10.1016/j.bmcl.2018.11.034
[4] Doig, A., del Castillo-Frias, M., Berthoumieu, O., Tarus, B., Nasica-Labouze, J., & Sterpone, F. et al. (2017). Why Is Research on Amyloid-β Failing to Give New Drugs for Alzheimer’s Disease?. ACS Chemical Neuroscience, 8(7), 1435-1437. doi: 10.1021/acschemneuro.7b00188
